Takeda Pharmaceutical Company Limited (TAK) Reports FY EPS of JPY484.00

Takeda Pharmaceutical Company Limited (NYSE: TAK) reported FY2023 EPS of JPY484.00. Revenue for the year came in at JPY4263.8 billion.

GUIDANCE:

Takeda Pharmaceutical Company Limited sees FY2024 EPS of JPY431.00. Takeda Pharmaceutical Company Limited sees FY2024 revenue of JPY4350 billion.

For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
• SpaceX receives Baa1 rating from Moody's with stable outlook